Juvena Therapeutics | $33,500,000 | (Jan 14, 2026)
bricks.sh | $1,863,303 | (Jan 14, 2026)
Allos | $5,000,000 | (Jan 14, 2026)
Key1 Capital
Israel
- Herzliya
- 09/11/2022
- Series A
- $15,000,000
Key1 Capital is a global investment firm focused on growth technology companies.
In forming Key1 Capital, the founders assembled a world class team of investment and operating professionals to work closely with promising global winners. The team has led the largest and most complex transactions in Israel and backed many of the preeminent technology companies which came out of the country.
Key1 Capital helps companies scale revenue faster, acquire first class managerial talent, pursue inorganic growth, execute larger and more complex financings, and prepare for and see through the ultimate exit.
- Industry Venture Capital and Private Equity Principals
- Website https://key1capital.com/
- LinkedIn https://www.linkedin.com/company/key1capital/
Related People
Nessim BoucaiInvestor
Israel -
ND
pecialties: European equity primary market, European credit and credit derivatives secondary market, marketing analysis, communication and writing
PayMedix | $33,000,000 | (Jan 14, 2026)
WeatherPromise | $12,800,000 | (Jan 14, 2026)
Diffraqtion | $4,200,000 | (Jan 14, 2026)
WithCoverage | $42,000,000 | (Jan 14, 2026)
Nodu | $1,450,000 | (Jan 14, 2026)
Cloudforce | $10,000,000 | (Jan 14, 2026)
Converge Bio | $25,000,000 | (Jan 14, 2026)
JetZero | $175,000,000 | (Jan 14, 2026)
TRYBE | $30,000,000 | (Jan 13, 2026)